Prevalence and Correlates of SARS CoV-2 Among a Community-Based Sample Recruited Using Randomized Venue-Based Sampling. Essex County, NJ, 2020Article Published on 2022-12-012022-11-15 Journal: Journal of racial and ethnic health disparities [Category] COVID19(2023년), SARS, 진단, [키워드] antibody black blood sample Care Community conducted correlates COVID-19 death determine Diagnosis disease Disparities disparity Factor help identify Infection Latinx morbidity and mortality New no significant difference outcome participant Participants PCR testing positive Prevalence provided public health reflected Sample sampling SARS CoV-2 SARS-CoV-2 antibodies Seroprevalence seroprevalence. stick suggested Surveillance Testing the disease Treatment underlying conditions upstream USA virus [DOI] 10.1007/s40615-021-01175-5 PMC 바로가기
Transmission of SARS-CoV-2 by children to contacts in schools and households: a prospective cohort and environmental sampling study in LondonArticle Published on 2022-11-012022-11-16 Journal: The Lancet. Microbe [Category] SARS, 변종, 치료기술, [키워드] acquisition Assessing Asymptomatic children Community Contact Contamination Department eight Evidence FIVE Frequency Genome sequencing Health household contact household contacts IMPROVE incident index case Infection Innovation Laboratory Local London occur PCR testing positive positive PCR positive SARS-CoV-2 PCR Precaution Prevent prospective cohort public health pupil Pupils quantified reduced representing rising SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA SARS-CoV-2 transmission School Schools secondary transmission Spread supported symptomatic individual tested Testing throat swab Transmission transmission of SARS-CoV-2 variant Ventilation viral shedding was done Weekly with COVID-19 [DOI] 10.1016/S2666-5247(22)00124-0 PMC 바로가기
Pandemic driven innovation: A pilot evaluation of an alternative respiratory pathogen collection deviceArticle Published on 2022-11-012022-11-16 Journal: The American journal of emergency medicine [Category] SARS, 유전자 메커니즘, [키워드] absence All participant amplification communicable disease COVID-19 demonstrated determine diagnostic enrolled evaluated faster favor feedback fused gold standard identify inhibitor Innovation Interpretation invasive mechanism nasopharyngeal Nasopharyngeal swab nucleic acids participant Patient PCR PCR cycle PCR testing pilot study polymerase chain positive producing real-time reverse transcriptase receiving respiratory respiratory pathogen respiratory virus Result resulting RNase P RNAseP RT-qPCR Self-collection respiratory pathogen device. specimen study participant TaqPath tested threshold [DOI] 10.1016/j.ajem.2022.08.047 PMC 바로가기
Ultrafast one-minute electronic detection of SARS-CoV-2 infection by 3CLpro enzymatic activity in untreated saliva samplesArticle Published on 2022-10-262022-11-15 Journal: Nature Communications [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] 3CLpro acute respiratory syndrome applicability approach Asymptomatic individuals carried caused clinical test coronavirus death detect enzymatic activity enzyme Infection marker PCR testing pH indicator platform point-of-care proteolytic proteolytic activity reliability Saliva SARS-CoV-2 SARS-COV-2 infection Sensitivity and specificity subject Transmission Viral transmission [DOI] 10.1038/s41467-022-34074-2 PMC 바로가기
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infectionArticle Published on 2022-10-172022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, [키워드] assays BNT162b2 BNT162b2 vaccine class correlated demonstrated develop dose doses epitope exhibited Frequency greater healthcare worker healthy IFN-γ IgG response IL-2 IL2 Immunity individual infected with SARS-CoV-2 Infection Interferon-gamma interleukin-2 magnitude Moderna mRNA-1273 vaccine mononuclear cell mRNA-1273 N and M nine participant Participants PCR testing peptide Peripheral blood Pfizer-BioNTech positive Post-infection Proteins proteome repeated responders response responses against robust S glycoprotein S1 and S2 S2 subunit SARS-CoV-2 SARS-COV-2 infection structural protein subunit subunits T cell response T-cell Response the SARS-CoV-2 uninfected vaccination vaccinee was determined were expressed with COVID-19 [DOI] 10.1371/journal.pone.0276241 PMC 바로가기
Self-sampling to identify pathogens and inflammatory markers in patients with acute sore throat: Feasibility studyArticle Published on 2022-10-062022-11-15 Journal: Frontiers in Immunology [Category] 바이오마커, 치료기술, [키워드] Analysis antibiotic Antibiotics approach Asymptomatic Bacterial bacterial pathogen benefit Biomarker Biomarkers children Concentration demonstrated detectable determine develop distribution Evidence Feasibility study feasible group help high risk identify Infection Inflammatory Inflammatory marker inflammatory markers media medium online tool Oropharyngeal participant pathogen Patient PCR PCR testing positive prevalence rates recruited reduce returned Saliva Self-swab sore sore throat sore throat diagnosis Support Swab swabs swabs. symptomatic and asymptomatic symptomatic participants tested throat swab Typical viral pathogen virus Volume [DOI] 10.3389/fimmu.2022.1016181 PMC 바로가기
Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variantsArticle Published on 2022-10-032022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] acute infection AEGIS amplification anomalies B.1.1.529 cause changes in characteristic conducted Corporation COVID-19 COVID-19 test Critical diagnose diagnostic diagnostic PCR tests effective Ensuring Evolution of SARS-CoV-2 Lineage lineages molecular Mutation observation omicron Patient PCR PCR testing Pharmacy polymerase chain proportion public health reduced reverse transcription RT-PCR S-gene SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Science Sequencing Surveillance the United State Transmission validation variant variants Viral transmission virus Walgreen whole genome [DOI] 10.1371/journal.pone.0275150 PMC 바로가기
Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 VaccineArticle Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] adverse event All participant antibody Antibody testing baseline ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine conducted coronavirus 2 cPass™ delta variant detectable detected antibody doses Dosing dosing interval dosing schedule Effectiveness Follow-up Genscript HCW HCWs healthcare worker IgG antibody immunization interval laboratory-confirmed neutralizing antibody no significant difference offer participant PCR testing performed Presence Prevalence prospective cohort study reported respiratory SARS-CoV-2 second dose Seroprevalence suggested the SARS-CoV-2 vaccination vaccination. Vaccine vaccine-induced antibodies worker [DOI] 10.1093/cid/ciac493 PMC 바로가기
Inpatient psychiatry response to the SARS-CoV-2 Omicron variant surgeArticle Published on 2022-10-012022-11-16 Journal: Psychiatry research [Category] COVID19(2023년), SARS, 변종, [키워드] Admission Admissions affected COVID-19 COVID-19 negative hospital hospitals implementation Infection infection control Inpatient occurred omicron Omicron variant Patient PCR PCR testing polymerase chain positive Psychiatric Psychiatric hospitals. psychiatry rapid increase required SARS-CoV-2 subsequent the SARS-CoV-2 the SARS-CoV-2 virus Transmissibility variant [DOI] 10.1016/j.psychres.2022.114746 PMC 바로가기
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infectionArticle Published on 2022-09-302022-11-15 Journal: Journal of Antimicrobial Chemotherapy [Category] SARS, 치료제, [키워드] 95% CI adverse event antibody Antiviral effect ARMS clinical trial clinical trials control arm COVID-19 infection COVID-19 symptom criteria enrolled evaluated experimental arm Frequency had no healthcare worker high risk in vitro incidence rate Infection infection with SARS-CoV-2 nitazoxanide no significant difference participant PCR testing Poisson regression model positive SARS-CoV-2 PCR primary endpoint randomization Randomized randomized trial risk safety analysis SARS-CoV-2 SARS-COV-2 infection serology shown sofosbuvir/daclatasvir South Africa Symptoms the primary endpoint Treatment Trial was selected was used [DOI] 10.1093/jac/dkac266 PMC 바로가기